Earnings
GWPH
218.96
-0.15%
-0.32
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
486.75M
--
--
71.17M
--
--
0.00
--
129.14M
--
42.47M
--
729.53M
168.88M
--
--
--
6.96M
5.57M
--
28.57M
209.98M
939.51M
--
21.87M
0.00
--
--
--
--
--
134.06M
--
--
--
2.88M
159.81M
14.30M
--
--
--
24.32M
38.62M
198.42M
577.00K
1.69B
-896.09M
--
--
--
741.09M
741.09M
939.51M
FY 2019-12-31
536.93M
--
--
48.88M
--
--
0.00
--
85.53M
--
28.29M
--
699.64M
152.68M
--
--
--
6.96M
--
--
22.97M
182.61M
882.25M
--
--
0.00
--
--
--
9.99M
--
105.28M
--
--
--
1.40M
117.56M
14.72M
--
--
--
23.93M
38.65M
156.22M
570.00K
1.63B
-837.96M
--
--
--
726.03M
726.03M
882.25M
FY 2018-09-30
354.91M
--
--
2.12M
--
--
0.00
--
19.06M
--
14.62M
--
390.71M
82.38M
--
--
--
6.96M
--
--
10.48M
99.82M
490.54M
--
9.74M
0.00
--
--
--
9.74M
--
46.74M
--
--
--
2.19M
58.67M
1.53M
--
--
--
15.17M
16.71M
75.38M
530.00K
1.25B
-757.03M
--
--
--
415.16M
415.16M
490.54M
FY 2017-09-30
335.45M
--
--
1.42M
--
--
31.69M
--
5.90M
--
10.41M
--
384.87M
60.91M
--
--
--
7.25M
1.28M
--
8.74M
78.18M
463.05M
--
8.08M
0.00
--
--
--
7.76M
--
10.50M
--
--
--
31.86M
50.72M
6.61M
--
--
--
18.80M
25.41M
76.14M
422.83K
774.13M
-387.64M
--
--
--
386.91M
386.91M
463.05M
FY 2017-09-30
320.16M
--
--
1.36M
--
--
30.25M
--
5.63M
--
9.93M
--
367.33M
58.14M
--
--
--
6.92M
1.22M
--
8.34M
74.61M
441.94M
--
7.71M
0.00
--
--
--
43.97M
--
10.03M
--
--
--
30.41M
48.41M
16.88M
--
--
--
7.38M
24.25M
72.67M
403.56K
738.85M
-369.97M
--
--
--
369.28M
369.28M
441.94M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out GWPH latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze GW Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.